Kortylewicz ZP - Search Results

1

Radiolabeled constructs for evaluation of the asialoglycoprotein receptor status and hepatic functional reserves.

Abe M, Lai J, Kortylewicz ZP, Nagata H, Fox IJ, Enke CA, Baranowska-Kortylewicz J. Abe M, et al. Among authors: kortylewicz zp. Bioconjug Chem. 2003 Sep-Oct;14(5):997-1006. doi: 10.1021/bc034081a. Bioconjug Chem. 2003. PMID: 13129404

2

Effect of platelet-derived growth factor receptor-beta inhibition with STI571 on radioimmunotherapy.

Baranowska-Kortylewicz J, Abe M, Pietras K, Kortylewicz ZP, Kurizaki T, Nearman J, Paulsson J, Mosley RL, Enke CA, Ostman A. Baranowska-Kortylewicz J, et al. Among authors: kortylewicz zp. Cancer Res. 2005 Sep 1;65(17):7824-31. doi: 10.1158/0008-5472.CAN-04-3991. Cancer Res. 2005. PMID: 16140951 Free PMC article.

3

Radioiodinated agents for imaging multidrug resistant tumors.

Kortylewicz ZP, Augustine AM, Nearman J, McGarry J, Baranowska-Kortylewicz J. Kortylewicz ZP, et al. Med Chem. 2009 Mar;5(2):171-81. doi: 10.2174/157340609787582954. Med Chem. 2009. PMID: 19275716

4

Radiolabeled 5-iodo-3'-O-(17beta-succinyl-5alpha-androstan-3-one)-2'-deoxyuridine and its 5'-monophosphate for imaging and therapy of androgen receptor-positive cancers: synthesis and biological evaluation.

Kortylewicz ZP, Nearman J, Baranowska-Kortylewicz J. Kortylewicz ZP, et al. J Med Chem. 2009 Aug 27;52(16):5124-43. doi: 10.1021/jm9005803. J Med Chem. 2009. PMID: 19653647 Free PMC article.

5

Radiolabeled cyclosaligenyl monophosphates of 5-iodo-2'-deoxyuridine, 5-iodo-3'-fluoro-2',3'-dideoxyuridine, and 3'-fluorothymidine for molecular radiotherapy of cancer: synthesis and biological evaluation.

Kortylewicz ZP, Kimura Y, Inoue K, Mack E, Baranowska-Kortylewicz J. Kortylewicz ZP, et al. J Med Chem. 2012 Mar 22;55(6):2649-71. doi: 10.1021/jm201482p. Epub 2012 Mar 8. J Med Chem. 2012. PMID: 22339166 Free PMC article.

6

Preclinical evaluation of investigational radiopharmaceutical RISAD-P intended for use as a diagnostic and molecular radiotherapy agent for prostate cancer.

Kortylewicz ZP, Mack E, Enke CA, Estes KA, Mosley RL, Baranowska-Kortylewicz J. Kortylewicz ZP, et al. Prostate. 2015 Jan;75(1):8-22. doi: 10.1002/pros.22885. Epub 2014 Oct 4. Prostate. 2015. PMID: 25283970

7

In vitro and in vivo evaluation of radiolabeled methyl N-[5-(3'-halobenzoyl)-1H-benzimidazol-2-yl]carbamate for cancer radiotherapy.

Kortylewicz ZP, Coulter DW, Baranowska-Kortylewicz J. Kortylewicz ZP, et al. Drug Dev Res. 2020 Feb;81(1):62-69. doi: 10.1002/ddr.21604. Epub 2019 Oct 8. Drug Dev Res. 2020. PMID: 31593323

8

Co-targeting androgen receptor and DNA for imaging and molecular radiotherapy of prostate cancer: in vitro studies.

Han G, Kortylewicz ZP, Enke T, Baranowska-Kortylewicz J. Han G, et al. Among authors: kortylewicz zp. Prostate. 2014 Dec;74(16):1634-46. doi: 10.1002/pros.22880. Epub 2014 Sep 11. Prostate. 2014. PMID: 25214432

9

Radiosynthesis of microtubule-targeted theranostic methyl N-[5-(3'-radiohalobenzoyl)-1H-benzimidazol-2-yl]carbamates.

Kortylewicz ZP, Baranowska-Kortylewicz J. Kortylewicz ZP, et al. J Labelled Comp Radiopharm. 2018 Apr 29:10.1002/jlcr.3631. doi: 10.1002/jlcr.3631. Online ahead of print. J Labelled Comp Radiopharm. 2018. PMID: 29707803 Free PMC article.

10

Norepinephrine-Transporter-Targeted and DNA-Co-Targeted Theranostic Guanidines.

Kortylewicz ZP, Coulter DW, Han G, Baranowska-Kortylewicz J. Kortylewicz ZP, et al. J Med Chem. 2020 Mar 12;63(5):2051-2073. doi: 10.1021/acs.jmedchem.9b00437. Epub 2019 Jul 3. J Med Chem. 2020. PMID: 31268317

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters